Incyte Biosciences Japan Gk

This study is testing a drug called axatilimab for Japanese patients with chronic graft-versus-host disease (cGVHD) that has come back or hasn't improved after at least two prior treatments. The goal is to see if the drug can reduce the severity of the disease and improve symptom…

This study is testing several combinations of a drug called tafasitamab, along with other medications, for Japanese adults with Non-Hodgkin Lymphoma. The main goals are to find safe doses and see how well these combinations work to control the cancer. It includes people whose can…